Uploaded October 2019 | Updated November 2026, 3 hours ago
Fewer than half of the first generics (the first to compete with brand-name drugs) approved by FDA since 2016 are commercially available to patients. Of those that are commercially available, only half are included on formularies of Medicare Part D plans. That doesn’t add up.
Learn more: doesntaddup.com
Fewer than half of the first generics (the first to compete with brand-name drugs) approved by FDA since 2016 are commercially available to patients. Of those that are commercially available, only half are included on formularies of Medicare Part D plans. That doesn’t add up.
Learn more: doesntaddup.com










